Cited by 1,573Schizophrenia research and treatmentPsychological Testing and AssessmentMental Health and Psychiatry

The DOI matches its Crossref record; 25 of the 27 references it cites were found in a registry or an index.

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery

Keefe, R·2004·Schizophrenia Research

DOI 10.1016/j.schres.2003.09.011

Open this paper in CoChat — free account

Abstract

Studies of neurocognitive function in patients with schizophrenia use widely variable assessment techniques. Clinical trials assessing the cognitive enhancing effect of new medications have used neurocognitive assessment batteries that differed in content, length and administration procedures. The Brief Assessment of Cognition in Schizophrenia (BACS) is a newly developed instrument that assesses the aspects of cognition found to be most impaired and most strongly correlated with outcome in patients with schizophrenia. The BACS requires less than 35 min to complete in patients with schizophrenia, yields a high completion rate in these patients, and has high reliability. The BACS was found to be as sensitive to cognitive impairment in patients with schizophrenia as a standard battery of tests that required over 2 h to administer. Compared to healthy controls matched for age and parental education, patients with schizophrenia performed 1.49 standard deviations lower on a composite score calculated from the BACS and 1.61 standard deviations lower on a composite score calculated from the standard battery. The BACS composite scores were highly correlated with the standard battery composite scores in patients (r=0.76) and healthy controls (r=0.90). These psychometric properties make the BACS a promising tool for assessing cognition repeatedly in patients with schizophrenia, especially in clinical trials of cognitive enhancement.

Integrity signals

Registry

Crossref · 10.1016/j.schres.2003.09.011

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

“Mini-mental state”
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
A new rating scale for Alzheimer's disease
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175
What are the functional consequences of neurocognitive deficits in schizophrenia?
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.3.321 · Cited by 3,516
Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the ‘‘right stuff’’?
Green, M. F., Kern, R. S., Braff, D. L., & Mintz, J. (2000) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033430 · Cited by 2,999
Untitled work
(1995) · Cited by 2,809
Neurocognitive deficit in schizophrenia: A quantitative review of the evidence.
Heinrichs, R. W., & Zakzanis, K. K. (1998) · Neuropsychology · doi:10.1037/0894-4105.12.3.426 · Cited by 2,798
Neuropsychological Function in Schizophrenia
Saykin, A. J. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810310036007 · Cited by 1,160
Auditory Working Memory and Wisconsin Card Sorting Test Performance in Schizophrenia
Gold, J. M. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830140071013 · Cited by 823
Impaired Attention, Genetics, and the Pathophysiology of Schizophrenia
Cornblatt, B. A., & Keilp, J. G. (1994) · Schizophrenia Bulletin · doi:10.1093/schbul/20.1.31 · Cited by 666
Studies of Cognitive Change in Patients With Schizophrenia Following Novel Antipsychotic Treatment
Harvey, P. D., & Keefe, R. S. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.2.176 · Cited by 617

Flagged first, then by citations

Show all 27 references

2 of the 27 references couldn’t be matched to a known paper.

Sorted by citations

Items 901–1,000 of 1,000

Haloperidol versus second-generation antipsychotics on the cognitive performance of individuals with schizophrenia and related disorders: pairwise meta-analysis of randomized controlled trials
Baldez, D. P., Biazus, T. B., Rabelo‐da‐Ponte, F. D., Nogaro, G. P., Martins, D. S., Signori, J. P. S., Gnielka, V., Passos, I. C., Czepielewski, L. S., & Kunz, M. (2023) · Trends in Psychiatry and Psychotherapy · doi:10.47626/2237-6089-2023-0664 · Cited by 9
Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy
Martini, F., Spangaro, M., Bechi, M., Agostoni, G., Buonocore, M., Sapienza, J., Nocera, D., Ave, C., Cocchi, F., Cavallaro, R., et al. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01731-6 · Cited by 12
Effect of Computer-Assisted Cognitive Remediation Therapy on Cognition among Patients with Schizophrenia: A Pilot Randomized Controlled Trial
Yamanushi, A., Shimada, T., Koizumi, A., & Kobayashi, M. (2024) · Biomedicines · doi:10.3390/biomedicines12071498 · Cited by 10
Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample
Allott, K., Yassin, W., Alameda, L., Billah, T., Borders, O., Buccilli, K., Carrión, R. E., Castillo-Passi, R. I., Cho, K. I. K., Chin, K., et al. (2025) · Schizophrenia · doi:10.1038/s41537-025-00578-1 · Cited by 9
Neutrophil-to-lymphocyte ratio; platelet-to-lymphocyte ratio; systemic immune-inflammatory Index: inflammatory indicators of cognitive impairment in schizophrenia patients
Chen, K., Wang, L., Ning, H., Pan, H., & Zhang, W. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1552451 · Cited by 12
Network analysis of cognitive, oculomotor and speech parameters in schizophrenia
Shmukler, A. B., Kostyuk, G. P., Латанов, А. В., Сидорова, М. Ю., Anisimov, V. N., Zakharova, N. V., Karyakina, M., Reznik, A. M., Sokolov, A., Spektor, V. A., et al. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202012006254 · Cited by 9
Age-dependent statistical learning trajectories reveal differences in information weighting.
Herff, S. A., Zhen, S., Yu, R., & Agres, K. (2020) · Psychology and Aging · doi:10.1037/pag0000567 · Cited by 9
Self-assessment of social cognition in a sample of Lebanese in-patients with schizophrenia
Haddad, C., Salameh, P., Hallit, S. R., Sacre, H., Clément, J., & Calvet, B. (2021) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2021.100207 · Cited by 9
The Implementation and Review of Cognitive Remediation Training for First Episode Psychosis in Singapore
Chong, N. I. M., Maniam, Y., Chua, Y. C., & Tang, C. Y. Z. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.784935 · Cited by 8
Twelve-Month Cognitive Trajectories in Individuals at Ultra-High Risk for Psychosis: A Latent Class Analysis
Allott, K., Schmidt, S. J., Yuen, H. P., Wood, S. J., Nelson, B., Markulev, C., Lavoie, S., Brewer, W. J., Schäfer, M. R., Mossaheb, N., et al. (2022) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgac008 · Cited by 9
Associations between saliva alpha-amylase, heart rate variability, saliva cortisol and cognitive performance in individuals at ultra high-risk for psychosis
Almstrup, F. B., Nordentoft, M., Jensen, M. A., Kristiansen, J., Kristensen, T. D., Wenneberg, C., Garde, A. H., Glenthøj, L. B., & Nordholm, D. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.03.041 · Cited by 9
Analysis of polyunsaturated fatty acids in antipsychotic-free individuals with at-risk mental state and patients with first-episode schizophrenia
Le, A. T. P., Higuchi, Y., Sumiyoshi, T., Itoh, H., Sasabayashi, D., Takahashi, T., & Suzuki, M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1188452 · Cited by 11
The relationship, structure and profiles of schizophrenia measurements: a post-hoc analysis of the baseline measures from a randomized clinical trial
Chen, L., Phillips, G. A., Johnston, J. A., Kinon, B. J., Ascher‐Svanum, H., Kollack‐Walker, S., Succop, P. S., & Naber, D. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-203 · Cited by 9
Development of brief versions of the Wechsler Intelligence Scale for schizophrenia: Considerations of the structure and predictability of intelligence
Sumiyoshi, C., Uetsuki, M., Suga, M., Kasai, K., & Sumiyoshi, T. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.08.024 · Cited by 9
The Singapore flagship programme in translational and clinical research in psychosis
Chong, S. A., Campbell, A., Chee, M. W. L., Liu, J., Marx, C., McGorry, P. D., Subramaniam, M., Yung, A. R., & Keefe, R. S. E. (2011) · Early Intervention in Psychiatry · doi:10.1111/j.1751-7893.2011.00304.x · Cited by 9
Neurocognitive functioning in patients with first-episode schizophrenia 1 year from onset in comparison with patients 5 years from onset
Matsuda, Y., Sato, S., Hatsuse, N., Watanabe, Y., Kishimoto, T., & Ikebuchi, E. (2013) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2013.845220 · Cited by 9
Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study
Primavera, D., Manchia, M., Deriu, L., Tusconi, M., Collu, R., Scherma, M., Fadda, P., Fratta, W., & Carpiniello, B. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014938 · Cited by 8
Comparison of prefrontal hemodynamic responses and cognitive deficits between adult patients with autism spectrum disorder and schizophrenia
Pu, S., Nakagome, K., Satake, T., Ohtachi, H., Itakura, M., Yamanashi, T., Miura, A., Yokoyama, K., Matsumura, H., Iwata, M., et al. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.10.007 · Cited by 9
Neuropsychological features in patients with severe mental disorders and risk of violence: A prospective multicenter study in Italy
Gobbi, E., Cotelli, M., Manenti, R., Ferrari, C., Macis, A., Bianconi, G., Candini, V., Clerici, M., Ferla, M. T., Iozzino, L., et al. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113027 · Cited by 9
Organized Resting-state Functional Dysconnectivity of the Prefrontal Cortex in Patients with Schizophrenia
He, Y., Wu, S., Cheng Ann, C. H. E. N., Fan, L., Li, K., Wang, G., Wang, H., & Zhou, Y. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.08.021 · Cited by 9
Cognitive discrepancies, motivation and subjective well-being in people with schizophrenia
Krzyzanowski, D. J., Agid, O., Goghari, V. M., & Remington, G. J. (2021) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2021.100205 · Cited by 14
Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses
Nielsen, M. Ø., Kristensen, T. D., Bojesen, K. B., Glenthoj, B. Y., Lemvigh, C. K., & Ebdrup, B. H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.834333 · Cited by 9
Clinical efficacy and neurobiological correlates of electroconvulsive therapy in patients with clozapine-resistant/intolerant schizophrenia: study protocol of multi-site parallel arm double-blind randomized sham-controlled study
Arumugham, S. S., Praharaj, S. K., Shreekantiah, U., Sreeraj, V. S., Roy, C., Shenoy, S., Purohith, A. N., Uppinkudru, C., Bagali, K. B., Venkataramaiah, S., et al. (2022) · Wellcome Open Research · doi:10.12688/wellcomeopenres.18028.2 · Cited by 9
Antineuronal Autoantibodies in the Cerebrospinal Fluid and Serum From 106 Patients With Recent-Onset Depression Compared With 106 Individually Matched Healthy Control Subjects
Sørensen, N. V., Nilsson, A. C., Orlovska‐Waast, S., Jeppesen, R., Christensen, R. H. B., & Benros, M. E. (2022) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2022.10.007 · Cited by 11
Characterization of childhood trauma, hippocampal mediation and Cannabis use in a large dataset of psychosis and non-psychosis individuals
del Re, E. C., Yassin, W., Zeng, V., Keedy, S., Alliey‐Rodriguez, N., Ivleva, E. I., Hill, S., Rychagov, N., McDowell, J. E., Bishop, J. R., et al. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.03.029 · Cited by 9
Exploring current smartphone-based cognitive assessments in schizophrenia and bipolar disorder
Lane, E., Joshi, D., Guimond, S., Moore, R. C., Ahmed, A. O., Ajilore, O., & Torous, J. B. (2024) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2024.100309 · Cited by 9
Verbal working memory and functional outcome in patients with unipolar major depressive disorder
Kaneda, Y. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970903183705 · Cited by 9
Association of the Hermansky–Pudlak syndrome type 4 (HPS4) gene variants with cognitive function in patients with schizophrenia and healthy subjects
Kuratomi, G., Saito, A., Ozeki, Y., Watanabe, T., Fujii, K., Shimoda, K., Inukai, T., Mori, H., Ohmori, K., & Akiyama, K. (2013) · BMC Psychiatry · doi:10.1186/1471-244x-13-276 · Cited by 9
Glutamate EAAT1 transporter genetic variants influence cognitive deficits in bipolar disorder
Poletti, S., Locatelli, C., Pirovano, A., Colombo, C., & Benedetti, F. (2015) · Psychiatry Research · doi:10.1016/j.psychres.2014.12.071 · Cited by 9
The relationship of categorical and phonological verbal fluency to negative schizotypy and social functioning in a non-clinical sample
Dinzeo, T. J., Serna, V. C., Pujji, S. D., & Sledjeski, E. M. (2017) · Cognitive Neuropsychiatry · doi:10.1080/13546805.2017.1418307 · Cited by 9
Self-perceived cognitive impairments in psychosis ultra-high risk individuals: associations with objective cognitive deficits and functioning
Glenthøj, L. B., Mariegaard, L. S., Kristensen, T. D., Wenneberg, C., Medalia, A. A., & Nordentoft, M. (2020) · Schizophrenia · doi:10.1038/s41537-020-00124-1 · Cited by 9
A MEG Study of Visual Repetition Priming in Schizophrenia: Evidence for Impaired High-Frequency Oscillations and Event-Related Fields in Thalamo-Occipital Cortices
Sauer, A., Grent-‘t-Jong, T., Wibral, M., Grube, M., Singer, W., & Uhlhaas, P. J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.561973 · Cited by 11
Potential contribution of pineal atrophy and pineal cysts toward vulnerability and clinical characteristics of psychosis
Takahashi, T., Sasabayashi, D., Takayanagi, Y., Higuchi, Y., Mizukami, Y., Akasaki, Y., Nishiyama, S., Furuichi, A., Pham, T. V., Kobayashi, H., et al. (2021) · NeuroImage Clinical · doi:10.1016/j.nicl.2021.102805 · Cited by 9
The Endogenous Opioid System in Schizophrenia and Treatment Resistant Schizophrenia: Increased Plasma Endomorphin 2, and κ and μ Opioid Receptors are Associated with Interleukin-6Preprint
Moustafa, S. R., Al-Rawi, K. F., Al-Dujaili, A. H., Supasitthumrong, T., Al‐Hakeim, H. K., & Maes, M. H. J. (2020) · Preprints.org · doi:10.20944/preprints202001.0138.v1 · Cited by 9
Facilitative Effects of Transcranial Direct Current Stimulation on Semantic Memory Examined by Text-Mining Analysis in Patients With Schizophrenia
Sumiyoshi, C., Narita, Z. C., Inagawa, T., Yamada, Y., Sueyoshi, K., Hasegawa, Y., Shirama, A., Hashimoto, R., & Sumiyoshi, T. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.583027 · Cited by 9
Screening for cognitive impairment in schizophrenia: A comparison between the Mini-Mental State Examination and the Montreal Cognitive Assessment Test
Doğu, S. E., & Kokurcan, A. (2023) · Journal of Clinical Psychiatry · doi:10.5505/kpd.2023.67760 · Cited by 8
Effect of individualized occupational therapy on cognition among patients with schizophrenia: A randomized controlled trial
Shimada, T., Morimoto, T., Nagayama, H., Nakamura, N., Aisu, K., Kito, A., Kojima, R., Yamanushi, A., Kawano, K., Hikita, N., et al. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.04.018 · Cited by 9
The General Neurocognitive Decline in Patients with Methamphetamine Use and Transient Methamphetamine-induced Psychosis is Primarily Determined by Oxidative and AGE-RAGE Stress
Maes, M. H. J., Altufaili, M. F., Alhaideri, A. F., Moustafa, S. R., Stoyanova, K., Niu, M., Zhou, B., Li, J., & Al‐Hakeim, H. K. (2024) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266320808240709061445 · Cited by 8
Strategies for Achieving Better Cognitive Health in Individuals with Schizophrenia Spectrum: A Focus on the Canadian Landscape: Stratégies pour atteindre une meilleure santé cognitive chez les personnes souffrant du spectre de la schizophrénie : un regard sur le paysage canadien
Lepage, M., Guimond, S., Raedler, T. J., McNeely, H. E., Ungar, T., Margolese, H. C., & Best, M. W. (2024) · The Canadian Journal of Psychiatry · doi:10.1177/07067437241261928 · Cited by 8
Use and discontinuation of antipsychotic medication in 20 years following a first episode of schizophrenia: results from the OPUS trial
Hansen, H. G., Speyer, H., Stürup, A. E., Hjorthøj, C. R., Öngür, D., Nordentoft, M., & Albert, N. (2024) · Psychological Medicine · doi:10.1017/s0033291724002678 · Cited by 8
Mismatch Negativity (MMN) as a Pharmacodynamic/Response Biomarker for NMDA Receptor and Excitatory/Inhibitory Imbalance-Targeted Treatments in Schizophrenia
Javitt, D. C. (2024) · Advances in neurobiology · doi:10.1007/978-3-031-69491-2_15 · Cited by 8
Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study
Qurashi, I., Chu, S., Husain, N., Drake, R., Chaudhry, I. B., & Deakin, J. F. W. (2016) · Trials · doi:10.1186/s13063-016-1678-5 · Cited by 8
Neurocognitive impairments in patients with schizophrenia and schizophrenia spectrum disorders: cluster analysis results
Karyakina, M., & Shmukler, A. B. (2020) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2020-1-45-51 · Cited by 8
Distinct neuroanatomic subtypes in antipsychotic-treated patients with schizophrenia classified by the predefined classification in a never-treated sample
Zhao, Q., Li, J., Xiao, Y., Cao, H., Wang, X., Zhang, W., Li, S., Liao, W., Gong, Q., & Lui, S. (2021) · Psychoradiology · doi:10.1093/psyrad/kkab018 · Cited by 8
MR-Spectroscopy of GABA and Glutamate/Glutamine Concentrations in Auditory Cortex in Clinical High-Risk for Psychosis Individuals
Grent-‘t-Jong, T., Gajwani, R., Groß, J., Gumley, A. I., Lawrie, S. M., Schwannauer, M., Schultze‐Lutter, F., Williams, S. R., & Uhlhaas, P. J. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.859322 · Cited by 8
Cognitive dysfunction and disability in people living with schizophrenia
Srisudha, B., Kattula, D., Shanmugasundaram, D., & Rachana, A. (2022) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_396_21 · Cited by 8
Montreal Cognitive Assessment (MoCA) as a screening tool for cognitive impairment in early stages of psychosis
Corral, S. A., Gaspar, P. A., Castillo-Passi, R. I., Troncoso, R. M., Mundt, A. P., Ignatyev, Y., Nieto, R. R., & Figueroa-Muñoz, A. (2024) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2024.100302 · Cited by 8
Early prediction of mastery of a computerized functional skills training program in participants with mild cognitive impairment
Harvey, P. D., Dowell-Esquivel, C., Macchiarelli, J. E., Martínez, A., Kallestrup, P., & Czaja, S. J. (2024) · International Psychogeriatrics · doi:10.1017/s1041610224000115 · Cited by 8
The association of prolactin and gonadal hormones with cognition and symptoms in men with schizophrenia spectrum disorder: Divergent effects of testosterone and estrogen
Hamers, I. M. H., Brand, B. A., Begemann, M., Weickert, C. S., Weickert, T. W., & Sommer, I. E. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.06.022 · Cited by 8
Correlation between myelin basic protein levels in cerebrospinal fluid and motor speed in patients with schizophrenia
Enokida, T., Hattori, K., Ota, M., Tatsumi, M., Hidese, S., Sato, N., Hoshino, M., & Kunugi, H. (2024) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12471 · Cited by 7
Choroid plexus morphology in schizophrenia and early-stage psychosis: A cross-sectional study
Brunner, G., Gajwani, R., Groß, J., Gumley, A. I., Timmerman, R. H., Taylor, R., Krishnadas, R., Lawrie, S. M., Schwannauer, M., Schultze‐Lutter, F., et al. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.12.005 · Cited by 8
Abnormal Connectional Fingerprint in Schizophrenia: A Novel Network Analysis of Diffusion Tensor Imaging Data
Thanarajah, S. E., Han, C. E., Rotarska-Jagiela, A., Singer, W., Deichmann, R., Maurer, K., Kaiser, M., & Uhlhaas, P. J. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00114 · Cited by 8
The influence of negative and affective symptoms on anhedonia self-report in schizophrenia
Barnham, I. J., Saleh, Y., Masud Husain, B., Kirkpatrick, B. W., & Fernández-Egea, E. (2020) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2020.152165 · Cited by 8
Neuropsychological deficits correlate with symptoms severity and cortical thickness in Borderline Personality Disorder
Vai, B., Cazzetta, S., Scalisi, R., Donati, A., Bechi, M., Poletti, S., Sforzini, L., Visintini, R., Maffei, C., & Benedetti, F. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.060 · Cited by 10
Combining compensatory cognitive training and medication self-management skills training, in inpatients with schizophrenia: A three-arm parallel, single-blind, randomized controlled trial
Zhu, X., Song, H. S., Chang, R., Chen, B., Song, Y., Liu, J., & Wang, K. (2020) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.12.012 · Cited by 8
Associations between cognition and white matter microstructure in first-episode antipsychotic-naïve patients with schizophrenia and healthy controls: A multivariate pattern analysis
Thomas, M. B., Raghava, J. M., Pantelis, C., Rostrup, E., Nielsen, M. Ø., Jensen, M. H., Glenthoj, B. Y., Mandl, R. C. W., Ebdrup, B. H., & Fagerlund, B. (2021) · Cortex · doi:10.1016/j.cortex.2021.03.003 · Cited by 9
Deficits in generalized cognitive ability, visual sensorimotor function, and inhibitory control represent discrete domains of neurobehavioral deficit in psychotic disorders
Eskridge, C. L. M., Hochberger, W. C., Kaseda, E. T., Lencer, R., Reilly, J. L., Keedy, S., Keefe, R. S. E., Pearlson, G. D., Keshavan, M. S., Tamminga, C. A., et al. (2021) · Schizophrenia Research · doi:10.1016/j.schres.2021.07.036 · Cited by 8
Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial
Rasmussen, J. Ø., Jennum, P., Línnet, K., Glenthoj, B. Y., & Baandrup, L. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03395-9 · Cited by 8
Immunological investigations of the cerebrospinal fluid in patients with recent onset psychotic disorders: A study protocol
Jeppesen, R., Orlovska‐Waast, S., Sørensen, N. V., Christensen, R. H. B., & Benros, M. E. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257946 · Cited by 8
Verbal Memory
Sumiyoshi, T. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-16522-6_8 · Cited by 8
Schizophrenia Spectrum and Other Psychotic Disorders
(2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9780890425787.x02_schizophrenia_spectrum · Cited by 12
The α2C-adrenoceptor antagonist JP-1302 controls behavioral parameters, tyrosine hydroxylase activity and receptor expression in a rat model of ketamine-induced schizophrenia-like deficits
Tekin, N., Karamahmutoğlu, T. E., Aykaç, A., Akakın, D., & Gören, M. Z. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173490 · Cited by 8
Clustering of antipsychotic-naïve patients with schizophrenia based on functional connectivity from resting-state electroencephalography
Ambrosen, K. S., Fredriksson, F., Anhøj, S. J., Bak, N. K., van Dellen, E., Dominicus, L. S., Lemvigh, C. K., Sørensen, M. E., Nielsen, M. Ø., Bojesen, K. B., et al. (2023) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-023-01550-9 · Cited by 8
Self-reported social functioning and prefrontal hemodynamic responses during a cognitive task in schizophrenia
Pu, S., Nakagome, K., Itakura, M., Yamanashi, T., Sugie, T., Miura, A., Satake, T., Iwata, M., Nagata, I., & Kaneko, K. (2015) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2015.09.008 · Cited by 8
Relationship between clinical improvement and functional gains with clozapine in schizophrenia
Lee, J., Takeuchi, H., Fervaha, G., Bhaloo, A., Powell, V., & Remington, G. J. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.08.003 · Cited by 8
Daily activity patterns in remitted first-episode schizophrenia
Fervaha, G., Agid, O., McDonald, K., Foussias, G., & Remington, G. J. (2014) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2014.04.001 · Cited by 8
Comparing the Influences of Age and Disease on Distortion in the Clock Drawing Test in Japanese Patients With Schizophrenia
Kaneda, A., Yasui‐Furukori, N., Umeda, T., Sugawara, N., Tsuchimine, S., Saito, M., Sato, Y., Furukori, H., Takahashi, I., Nakaji, S., et al. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181ef7a47 · Cited by 8
Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design
Nasib, L. G., Sommer, I. E., Rossum, I. W.-V., de Vries, J., Gangadin, S. S., Oomen, P. P., Judge, G., Blom, R. E., Luykx, J. J., van Beveren, N. J. M., et al. (2020) · Trials · doi:10.1186/s13063-020-04365-4 · Cited by 8
Convergence of Clinical Staff Ratings and Research Ratings to Assess Patients With Schizophrenia in Nursing Homes
Bowie, C. R., Fallon, C., & Harvey, P. D. (2006) · Psychiatric Services · doi:10.1176/appi.ps.57.6.838 · Cited by 8
The interleukin-6/interleukin-23/Thelper-17-axis as a driver of neuro-immune toxicity in the major neurocognitive psychosis or deficit schizophrenia: a precision nomothetic psychiatry analysisPreprint
Al‐Hakeim, H. K., Alhusseini, A. F., Al-Dujaili, A. H., Debnath, M., & Maes, M. H. J. (2022) · medRxiv · doi:10.1101/2022.02.23.22271393 · Cited by 8
Investigating disorder-specific and transdiagnostic alterations in model-based and model-free decision-making
Knolle, F., Sen, P., Culbreth, A., Koch, K., Schmitz-Koep, B., Gürsel, D. A., Wunderlich, K., Avram, M., Berberich, G., Sorg, C., et al. (2024) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.240020 · Cited by 9
The Cognition Self-Assessment Rating Scale for patients with schizophrenia
Nasrallah, H. A. (2023) · Current Psychiatry · doi:10.12788/cp.0335 · Cited by 7
The self-assessment scale of cognitive complaints in Schizophrenia: validation of the Arabic version among a sample of lebanese patients
Haddad, C., Sacre, H., Abboche, E., Salameh, P., & Calvet, B. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04925-3 · Cited by 7
Striatal Response to Reward Anticipation as a Biomarker for Schizophrenia and Negative Symptoms: Effects, Test-Retest Reliability, and Stability Across Sites
Carruzzo, F., Kaliuzhna, M., Kuenzi, N., Geffen, T., Katthagen, T., Schlagenhauf, F., & Kaiser, S. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae046 · Cited by 7
Resting-state electroencephalogram in drug-free subjects with at-risk mental states who later developed psychosis: a low-resolution electromagnetic tomography analysis
Higuchi, Y., Odagiri, S., Tateno, T., Suzuki, M., & Takahashi, T. (2024) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2024.1449820 · Cited by 7
Severity of autism-related symptoms in treatment-resistant schizophrenia: associations with cognitive performance, psychosocial functioning, and neurological soft signs — Clinical evidence and ROC analysis
Vellucci, L., Barone, A., Buonaguro, E. F., Ciccarelli, M., Simone, G. D., Iannotta, F., Matrone, M., Mazza, B., Vitelli, R., de Bartolomeis, A., et al. (2025) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2025.03.040 · Cited by 7
Transcranial direct current stimulation (tDCS) for cognitive impairment in schizophrenia: A systematic review and meta-analysis of randomized controlled trials
Fernandez, L. G., Gualán, A. P. M., Romero‐Ferreiro, V., Padilla, S., Santos, D. D. L., Cardona-Bejarano, S., Moleón-Ruiz, Á., García, M. M.-B., Wynn, R., & Rodríguez–Jiménez, R. (2025) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2025.111526 · Cited by 8
Design and validation of a brief scale for cognitive evaluation in people with a diagnosis of schizophrenia (BCog‐S)
Sánchez‐Martínez, V., & Orts, R. S. (2020) · Journal of Psychiatric and Mental Health Nursing · doi:10.1111/jpm.12602 · Cited by 8
Modifiable predictors of self-reported and performance-based functioning in individuals with schizophrenia-spectrum disorders and high levels of negative symptoms
Mahmood, Z., Parrish, E. M., Keller, A. V., Lykins, H. C., Pickell, D., Granholm, E. L., & Twamley, E. W. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.04.039 · Cited by 7
Relationships between erythrocyte membrane mono- and poly- unsaturated fatty acid composition and clinical/cognitive indices in antipsychotic-free schizophrenia patients
Higuchi, Y., Takahashi, T., Itoh, H., Sasabayashi, D., Sumiyoshi, T., & Suzuki, M. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1361997 · Cited by 8
Striatal Functional Hypoconnectivity in Patients With Schizophrenia Suffering From Negative Symptoms, Longitudinal Findings
Geffen, T., Hardikar, S., Smallwood, J., Kaliuzhna, M., Carruzzo, F., Böge, K., Zierhut, M. M., Gutwinski, S., Katthagen, T., Kaiser, S., et al. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae052 · Cited by 10
Cognitive Mechanisms of Aberrant Self-Referential Social Perception in Psychosis and Bipolar Disorder: Insights From Computational Modeling
Lasagna, C. A., Tso, I. F., Blain, S. D., & Pleskac, T. J. (2024) · Schizophrenia Bulletin · doi:10.1093/schbul/sbae147 · Cited by 10
Cortisol and C-reactive protein (CRP) regulation in severe mental disorders
Inova, A., Birkenæs, V., Quintana, D. S., Ormerod, M. B. E. G., Ueland, T., Ueland, T., Djurovic, S., Andreassen, O. A., Steen, N. E., & Aas, M. (2024) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2024.107272 · Cited by 10
A Case Study of Clozapine and Cognition
Savulich, G., Mezquida, G., Atkinson, S., Bernardo, M., & Fernández-Egea, E. (2018) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000847 · Cited by 7
Cognitive Enhancement in Schizophrenia and Related Disorders
Keshavan, M. S., & Eack, S. M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108163682 · Cited by 7
Do neurobiological differences exist between paranoid and non-paranoid schizophrenia? Findings from the bipolar schizophrenia network on intermediate phenotypes study
Lutz, O., Lizano, P. L., Mothi, S. S., Zeng, V., Hegde, R. R., Hoang, D. T., Henson, P., Brady, R. O., Tamminga, C. A., Pearlson, G. D., et al. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.02.011 · Cited by 7
Cognitive Impairment in Schizophrenia: An Overview of Assessment and Management
Halder, S., & Mahato, A. K. (2015) · International Journal of Indian Psychology · doi:10.25215/0204.047 · Cited by 7
Exploring Movement Impairments in Patients With Parkinson's Disease Using the Microsoft Kinect Sensor: A Feasibility Study
Rudå, D., Einarsson, G., Andersen, A. S. S., Matthiassen, J. B., Correll, C. U., Winge, K., Clemmensen, L. K. H., Paulsen, R. R., Pagsberg, A. K., & Fink‐Jensen, A. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.610614 · Cited by 7
Duration of basic and attenuated-psychotic symptoms in individuals at clinical high risk for psychosis: pattern of symptom onset and effects of duration on functioning and cognition
Staines, L., Gajwani, R., Groß, J., Gumley, A. I., Lawrie, S. M., Schwannauer, M., Schultze‐Lutter, F., & Uhlhaas, P. J. (2021) · BMC Psychiatry · doi:10.1186/s12888-021-03267-2 · Cited by 7
Subjectively-assessed cognitive impairment and neurocognition associations in schizophrenia inpatients
Masuzawa, T., Hashimoto, T., & Yotsumoto, K. (2021) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2021.100218 · Cited by 7
Multimodal Dataset of Social Skills Training in Natural Conversational Setting
Saga, T., Tanaka, H., Iwasaka, H., Matsuda, Y., Morimoto, T., Uratani, M., Okazaki, K., Fujimoto, Y., & Nakamura, S. (2021) · Companion Publication of the International Conference on Multimodal Interaction (ICMI Companion) · doi:10.1145/3461615.3485425 · Cited by 7
Three prominent self-report risk measures show unique and overlapping utility in characterizing those at clinical high-risk for psychosis
Williams, T. F., Powers, A. R., Ellman, L. M., Corlett, P. R., Strauss, G. P., Schiffman, J. E., Waltz, J. A., Silverstein, S. M., Woods, S. W., Walker, E. F., et al. (2022) · Schizophrenia Research · doi:10.1016/j.schres.2022.05.006 · Cited by 7
Probing the Association between Cognition, Suicidal Behavior and Tryptophan Metabolism in a Sample of Individuals Living with Bipolar Disorder: A Secondary Analysis
Paribello, P., Squassina, A., Pisanu, C., Meloni, A., Dall’Acqua, S., Sut, S., Nasini, S., Bertazzo, A., Congiu, D., Garzilli, M., et al. (2023) · Brain Sciences · doi:10.3390/brainsci13040693 · Cited by 8
Modeling Effort-Based Decision Making: Individual Differences in Schizophrenia and Major Depressive Disorder
Saperia, S., Felsky, D., Silva, S. D., Siddiqui, I., Rector, N. A., Remington, G. J., Zakzanis, K. K., & Foussias, G. (2023) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2023.05.009 · Cited by 8
Cognitive aspects of schizophrenia
Harvey, P. D. (2013) · Wiley Interdisciplinary Reviews Cognitive Science · doi:10.1002/wcs.1253 · Cited by 8
Identifying attentional deficits in people with first-episode psychosis with the Scale for the Assessment of Negative Symptoms attention subscale: is it possible?
González‐Blanch, C., Priede, A., Rodríguez-Sánchez, J. M., Pérez‐Iglesias, R., Vázquez‐Barquero, J. L., & Crespo‐Facorro, B. (2011) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2011.11.007 · Cited by 7
A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcome
Rodríguez-Toscano, E., López, G., Mayoral, M., Lewis, S. W., Lees, J., Drake, R., Arango, C., & Rapado‐Castro, M. (2019) · Schizophrenia Research · doi:10.1016/j.schres.2019.11.018 · Cited by 7
The genetic variations in SAP97 gene and the risk of schizophrenia in the Chinese Han population: a further study
Xu, X., Wang, Y., Zhou, X., Yin, J., Yu, H., Xia, W., Lv, D., Zhu, D., Xiong, S., Yan, H., et al. (2020) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000257 · Cited by 7
Smoking Is Related to Reduced Motivation, But Not Global Cognition, in the First Two Years of Treatment for First Episode Psychosis
Schermitzler, B. S., Miley, K. M., Vinogradov, S., & Ramsay, I. S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081619 · Cited by 7
A novel digital intervention to facilitate diabetes self-management among people with schizophrenia and related disorders: development and acceptability testing of SMART
Arnautovska, U., Ritchie, G., Soole, R., Menon, A., Korman, N., Milton, A., Varnfield, M., Kelly, J., Jansen, P., Baker, A., et al. (2025) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s513272 · Cited by 7

Authors: Keefe, R.
Affiliations: Duke University (US)
Corresponding author: Keefe, R
ORCID: Keefe, R
Venue: Schizophrenia Research
Publisher: Elsevier BV
Published: 2004-06-01
Volume: 68
Issue: 2-3
Pages: 283-297
ISSN: 0920-9964 (ISSN-L)
DOI: 10.1016/j.schres.2003.09.011
OpenAlex: W2008062633
Cited by: 1,573
References: 27
Citations by year: 2026: 100 · 2025: 129 · 2024: 115 · 2023: 96 · 2022: 107 · 2021: 130 · 2020: 129 · 2019: 105 · 2018: 90 · 2017: 89 · 2016: 83 · 2015: 82 · 2014: 62 · 2013: 65 · 2012: 44
FWCI: 4.09
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Schizophrenia Research (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Social Sciences › Psychology › Applied Psychology › Psychological Testing and Assessment
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords: Brief Assessment of Cognition in Schizophrenia, schizophrenia
MeSH terms: Adult, Clinical Trials as Topic, Cognition Disorders, Female, Humans, Male, Neuropsychological Tests, Practice, Psychological, Psychometrics, Research Design, Schizophrenia, Schizophrenic Psychology, Sensitivity and Specificity, Antipsychotic Agents, Reproducibility of Results

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks